Skip to main content
CellaVision logo

CellaVision — Investor Relations & Filings

Ticker · CEVI ISIN · SE0000683484 LEI · 529900IUBZBZ0HXFJ114 ST Manufacturing
Open in API
Filings indexed 388 across all filing types
Latest filing 2011-01-12 Board/Management Inform…
Country SE Sweden
Listing ST CEVI

About CellaVision

https://www.cellavision.com/

CellaVision is a medical technology company that provides digital solutions for cell morphology in hematology. The company specializes in automating and standardizing the analysis of blood and other body fluids for both human and veterinary applications. Its core offerings include a complete system of analyzers, instruments, software, and reagents designed for hematology laboratories of all sizes. By utilizing patented technology that integrates automated microscopy, advanced image analysis, and artificial intelligence, CellaVision's systems digitize the traditional manual review of blood smears. This automation enhances laboratory workflow efficiency, improves diagnostic accuracy, and facilitates remote collaboration among healthcare professionals, advancing diagnostic certainty.

Recent filings

Filing Released Lang Actions
CellaVision reinforces management team with a Chief Operating Officer
Board/Management Information Classification · 1% confidence The document explicitly announces the hiring of a new senior executive, Stefan Bengtsson, as Chief Operating Officer (COO). The text details his responsibilities, background, and quotes from the CEO regarding the strategic importance of this recruitment. This directly aligns with the definition of 'Board/Management Information' (MANG), which covers announcements of changes in senior management.
2011-01-12 English
Unilabs effektiviserar laboratorieverksamheten med analysinstrument från CellaVision
Regulatory Filings Classification · 1% confidence The document describes a commercial agreement between two companies, CellaVision and Unilabs, regarding the sale and installation of laboratory analysis instruments and software. It details the order, quotes from management, and background information on both companies. This content does not fit the definitions for standard regulatory filings (10-K, IR, ER, etc.), nor is it a formal announcement of a capital event, management change, or dividend. It is a press release announcing a significant business transaction/contract. Since there is no specific category for 'Business Contract Announcement' or 'Press Release', and the content is not a formal regulatory filing, the most appropriate fallback category is 'Regulatory Filings' (RNS), which serves as a general category for miscellaneous corporate announcements that do not fit elsewhere.
2010-12-21 Swedish
Unilabs streamlines laboratory operations with analyzers from CellaVision
Regulatory Filings Classification · 1% confidence The document text describes a business contract signing between CellaVision and Unilabs regarding the installation of laboratory analyzers and software. It details the scope of the order, quotes from the CEOs, and provides background information on both companies. This content is characteristic of a press release or a general business announcement, not a formal regulatory filing like a 10-K, an Earnings Release (ER), or a specific financial report (IR, AR). Since it is a general announcement that doesn't fit the specific categories like M&A (TAR), Director's Dealing (DIRS), or Capital Change (CAP), the most appropriate fallback category is Regulatory Filings (RNS), which often encompasses press releases or non-standard announcements. Given the document length (4638 chars) and content, it is not a Report Publication Announcement (RPA) which typically just announces the availability of another document.
2010-12-21 English
Major Shareholding Notification 2010
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding for 'Livförsäkrings AB Skandia' in 'CellaVision AB'. It explicitly mentions 'Reason for major shareholding notification Buy' and provides 'Before the transaction' and 'After the transaction' figures, including the resulting percentage of voting rights (6.82%). This structure is characteristic of a notification regarding a significant change in ownership, which corresponds to the Major Shareholding Notification category.
2010-12-06 English
Major Shareholding Notification 2010
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding for CellaVision AB, specifically noting that 'Life Equity Sweden KB' has distributed all its shares in CellaVision AB to its investors. The table shows a significant reduction in holdings, moving from 1,626,783 shares to 0 shares, and the document explicitly mentions 'Reason for major shareholding notification Other'. This structure and content strongly indicate a notification regarding a change in a significant ownership stake, which aligns with the definition of Major Shareholding Notification (MRQ). Although it describes a distribution, the core function is reporting the resulting change in ownership percentage/quantity.
2010-12-03 English
Tredje AP-fonden ny större ägare i CellaVision
Major Shareholding Notification Classification · 1% confidence The document announces that 'Tredje AP-fonden' (The Third AP Fund) has acquired a 5.9% stake in CellaVision, making it the fifth largest owner. This constitutes a notification of a change in significant share ownership, as it details a new entity crossing a notable ownership threshold and lists the top five owners. This aligns directly with the definition for Major Shareholding Notification (MRQ). The document is short and contains the core information, not just an announcement of a report.
2010-11-04 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.